You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

List of Excipients in API paroxetine hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing paroxetine hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Rebel Distributors Corp PAXIL paroxetine hydrochloride 21695-159 GLYCERYL BEHENATE
Rebel Distributors Corp PAXIL paroxetine hydrochloride 21695-159 HYPROMELLOSES
Rebel Distributors Corp PAXIL paroxetine hydrochloride 21695-159 LACTOSE MONOHYDRATE
Rebel Distributors Corp PAXIL paroxetine hydrochloride 21695-159 MAGNESIUM STEARATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Try a Trial

Excipients in ANDA-approved (generic) drugs containing paroxetine hydrochloride

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc paroxetine hydrochloride 0378-2003 CELLULOSE, MICROCRYSTALLINE
Mylan Pharmaceuticals Inc paroxetine hydrochloride 0378-2003 FERROSOFERRIC OXIDE
Mylan Pharmaceuticals Inc paroxetine hydrochloride 0378-2003 HYDROXYPROPYL CELLULOSE
Mylan Pharmaceuticals Inc paroxetine hydrochloride 0378-2003 HYPROMELLOSE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Try a Trial

Detailed excipient profiles for paroxetine hydrochloride

Excipient focus: ALUMINUM OXIDE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: CALCIUM PHOSPHATE

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COCHINEAL

Excipient focus: COPOVIDONE K25-31

Excipient focus: D&C RED NO. 30

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: DIMETHICONE 410

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL BEHENATE

Excipient focus: GLYCERYL DIBEHENATE

Excipient focus: GLYCERYL MONOSTEARATE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: METHYLPARABEN

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: PIGMENT RED 48

Excipient focus: POLACRILIN POTASSIUM

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 10000

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SACCHARIN SODIUM ANHYDROUS

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - HIPAA-ready chat for life sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group